Innate Pharma S.A. ADS (IPHA) News
Latest headlines that mention IPHA, newest first · each headline opens the original publisher
- Last price
- $1.54
- Day change
- +0.01%
- Next earnings
- —
IPHA headlines
latest coverageLacutamab advances toward accelerated approval as ADC pipeline expands.
IPHA news alerts
Get an alert by email or push when a new headline mentions IPHA.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.